drugset / Trial / NCT02393547
Lorcaserin for Preventing Weight Gain Among Smokers
NaSingle-groupOpen-labelTreatment
Summary
This will be an open label clinical trial with all subjects receiving both lorcaserin and varenicline with a primary aim of reducing post cessation weight gain.
Timeline
- Start
- 2013-09
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lorcaserin | Small molecule | 10 mg | — |
| Subject | Varenicline | Small molecule | 1 mg | — |